Recursion Pharmaceuticals
Thomas Ly has extensive experience in biostatistics, currently serving as Senior Director of Biostatistics at Recursion. Prior roles include Director of Biostatistics at Bristol Myers Squibb and Director of Biostatistics, Head of Hematological Malignancies at Fate Therapeutics Inc. Additionally, Thomas held the position of Associate Director of Biostatistics in Late-Stage Development at Heron Therapeutics, Inc., and also served as Sr. Manager of Biostatistics at Xencor.
This person is not in any teams
This person is not in any offices
Recursion Pharmaceuticals
13 followers
Recursion is a clinical-stage biotechnology company combining experimental biology and automation with artificial intelligence in a massively parallel system to efficiently discover potential drugs for diverse indications, including genetic disease, inflammation, immunology, and infectious disease.